158 - Special Feature Sections in Organic Process Research & Development: Hot Topics (S11E8)

You know how sometimes trying to figure out what's
really important, what's actually cutting edge
in pharmaceutical development feels like trying
to catch smoke? Oh, definitely. There's just
so much going on, so many different avenues.
Right. And that's where a journal like organic
process research and development. OPR and D it
really shines doesn't it kind of acts like a
filter it does it highlights What's genuinely
significant and what's really smart is how they
use these special feature sections? Yes, they
bring the most well the most crucial advancements
into really sharp focus They give it like a curated
map of the hottest areas exactly a map. I like
that So for you our listener, this is kind of
like getting a backstage pass, right? We're diving
into these special sections today to give you
a clearer picture, maybe uncover some surprising
trends getting serious attention. And this isn't
just our take. We're pulling this straight from
OPRND's own content, looking at how they spotlight
these new technologies and themes. So these special
sections, they're like a pulse check for the
whole field. That's a great way to put it. Yeah.
They tell us, you know, what are the big problems
people are tackling? What exciting solutions
are emerging? Where's the real innovation happening?
OK, so let's zoom in a bit. What's the actual
purpose? Why create these special sections instead
of just publishing papers normally? Well, instead
of having articles on, say, a breakthrough scattered
across different issues over months or years.
Right, you have to hunt them down. Exactly. These
sections gather them all in one place. You get
research papers, reviews, expert commentary,
all focused on one really timely important area.
Makes it much easier to get up to speed on something
specific. For sure. For researchers and, you
know, for anyone interested, it gives a solid
understanding without all that searching. And
one area you mentioned that they really highlight
is new technologies and process research. Sounds
important, but maybe a bit broad. What kind of
things fall into that umbrella? Well, one of
the biggest shifts, and OPRD has definitely flagged
this, is the move towards continuous flow chemistry.
Continuous flow. OK, so not the big vats we might
picture. Sort of, yeah. Instead of those large
batch reactors, imagine ingredients flowing continuously,
maybe through narrow tubes or channels. Plug
flow reactors are a common example. And the advantage
is? Control. Massive control. Every bit of the
reaction mixture sees the exact same conditions.
Temperature, pressure, time. Ah, okay. So you
get more consistent results. Much more consistent,
much more predictable. It's like choreographing
the molecules perfectly. That sounds way more
efficient. Have they showcased actual examples
in the journal? Oh, absolutely. Even back in
2012, there was research featured on developing
and scaling up a key pharmaceutical intermediate.
A 1H4 substituted imidazole using these continuous
plug flow reactors showed how much faster it
could be. Faster development, okay. And another
2012 study detailed a continuous route for making
inosol sulfonamide. Again, the emphasis was on
better efficiency, better control compared to
batch methods. So it's not just about speed then,
is there more to it? Definitely not just speed.
A 2015 article looked at a large -scale continuous
flow process, converting oximes into something
called fused bicyclic isoxazolidines. Right.
They framed that as a key example of process
intensification. Process intensification, meaning
getting more out with less in? Basically, yes.
Doing more with smaller equipment, less energy,
less waste. But maybe the most striking example
was for synthesizing beta -histine. OPR &D covered
that in 2021. Data histine. What was so special
about that one? It wasn't just faster. It was
hugely better for the environment, and frankly
for the economics too. Really? Environmentally
friendly? How did continuous flow help there?
Well, this specific process dramatically reduced
the amount of raw materials needed. Okay, less
input. And it completely eliminated the need
for nasty organic solvents and hydrochloric acid.
Wow. Okay, that's significant. Plus, it simplified
the whole cleanup stage afterwards, used less
alkali, and the total operation time was slashed.
massively reduced. So less waste less hazardous
stuff. Exactly. They calculated the process mass
intensity PMI it's called. Basically waste generated
per kilo of product is reduced by 50 percent.
50 percent reduction in waste. That's incredible.
That's a genuine game changer. It really is.
It shows the potential for much greener pharmaceutical
manufacturing. OK. So continuous flow is clearly
a major focus in these new technology sections.
What other kinds of new tech? have they featured?
Another really interesting area is how we analyze
the handedness of molecules. Chirality. Oh, chirality.
Left -handed versus right -handed molecules.
Crucial in pharma, right? Absolutely crucial.
Because the two mirror image forms in angiomers
can have totally different effects. One might
be the drug, the other inactive, or worse. Or
even harmful, yeah. So how is technology helping
there? OPRND highlighted a technique called microwave
three -wave mixing. Microwave three -wave mixing.
Sounds complex. It is pretty advanced. Yeah.
But it offers a novel and potentially very precise
way to measure that chirality, to distinguish
between those mirror images. There were references
to guides and applications from other journals
showing it's a developing field. OK, so. From
huge process changes like flow chemistry down
to incredibly fine details like measuring molecular
handedness with microwaves These sections cover
a lot of ground. They really do it reflects the
breadth of innovation in process research Now
the prompt also mentioned looking back specifically
mentioning sections planned for 2014 Even if
we don't have the exact titles from that year.
Can we make some educated guesses? based on recurring
themes What might have been hot topics back then?
That's a really good way to think about it. We
can definitely infer likely topics based on what's
consistently critical in pharmaceutical development.
Like what, for instance? Well, crystallization
and polymorphism, for starters. Ah, how drugs
form solids. Exactly. How they crystallize. And
the fact that the same drug can often crystallize
into multiple different structures. That's polymorphism.
It's always been hugely important. We've seen
books and discussions on it over many years.
Because the crystal form affects how the drug
actually performs in the body. Absolutely. Think
about carbon graphite versus diamond. Same element,
totally different properties. Right. It's similar
with drug polymorphs. Different forms can have
different solubilities, different stability,
which impacts everything from manufacturing to
how well the drug gets absorbed. So understanding
and controlling that would definitely be a hot
topic. For sure. Especially as regulatory agencies
were also sharpening their focus on solid state
properties around that time. QBD quality by design
principles really emphasize understanding that
variability. So, yeah, a special section on crystallization
or polymorphism in 2014 seems highly likely.
Makes sense. What else was probably a big focus
back then? Impurity analysis is another strong
candidate. Finding the unwanted stuff. Precisely.
Ensuring drug purity is paramount for safety.
There are handbooks dedicated to isolating and
identifying impurities. We've discussed strategies
for dealing with them. While negotiable, really.
Totally. Advancements in analytical techniques
for detecting, identifying, and quantifying trace
impurities, that would absolutely warrant a special
feature section. It's a constant challenge. Okay,
crystallization, impurities. Any other likely
contenders for 2014 hot topics? Structure activity
relationships, SAR studies probably feature too.
SAR figuring out how the molecules shape relates
to how well it works as a drug. Exactly that.
It's fundamental to drug discovery and development.
We know techniques like SAR by NMR were being
discussed. Applying SAR principles more effectively
in process development, maybe linking structure
to processability or stability, seems like a
natural fit for OPRND's focus. Right. Connecting
the molecule directly to how you make it efficiently
and safely? Yes. It bridges discovery and development.
So, okay, even without those exact 2014 titles,
we see this pattern. deep dives into really fundamental
aspects. Physical form, purity, how the molecule
works alongside these emerging innovative technologies
like continuous flow. Exactly, it shows that
dynamic interplay. The field builds on core knowledge
while constantly pushing the boundaries with
new tools and approaches. And the focus shifts
over time, right? Absolutely. Driven by new science,
regulatory changes, industry needs, what was
a major focus in 2014 might be more established
now, making way for newer hot topics in today's
special sections. And that's the value for you,
our listener. Keeping an eye on these OPRND special
features is like getting that shortcut, that
curated view of the current challenges and importantly
the opportunities. Right. It helps you stay informed
efficiently to grasp where the field is heading
without reading literally every paper published.
Okay, so let's quickly recap. We've seen OPRND
uses these special feature sections to shine
a spotlight on what's really buzzing in process
chemistry. We looked closely at new technologies,
especially the impact of continuous flow chemistry
making things faster, greener, more controlled.
And things like advanced chiral analysis using
techniques like microwave three wave mixing.
And we reason that back around 2014 core topics
like crystallization and polymorphism, impurity
analysis, and SAR studies were almost certainly
getting that special feature treatment too. It
paints a picture of a field constantly evolving
but always grounded in fundamental principles.
And it really highlights why OPRND is such a
key journal. It definitely does. Thinking about
all this rapid change, it makes you wonder, what
emerging technologies do you think might be the
focus for OPRND's special features in the near
future? That's a great question. Maybe AI and
process design, or advancements in biocatalysis.
Or maybe how the huge push for sustainability
will shape the next wave of hot topics in process
R &D. Lots to think about. Indeed. And whatever
they are, they'll be driving how we create the
next generation of medicines. Well, thanks for
taking this deep dive with us today. If you want
to explore these areas further yourself, definitely
check out Organic Process Research and Development.
It's a fantastic resource. Until next time.